Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naval Daver

Showing results (91-100 of 436) with videos related to

Pageof 44
Sort By:
American Journal of Hematology|January 23, 2016
Acute promyelocytic leukemia presented as a relapse of acute myeloid leukemiaCandida Vitale, Elias Jabbour, Xinyan Lu, et al.
Frontiers in Oncology|September 28, 2020
First Report of Sorafenib in Patients With Acute Myeloid Leukemia Harboring Non-Canonical <i>FLT3</i> MutationsNaval Daver, Allyson Price, Christopher B Benton, et al.
Blood Advances|January 4, 2018
Co-occurrence of <i>FLT3</i>-TKD and <i>NPM1</i> mutations defines a highly favorable prognostic AML groupPrajwal Boddu, Hagop Kantarjian, Gautam Borthakur, et al.
Leukemia Research|July 23, 2014
Phase II study of pomalidomide in combination with prednisone in patients with myelofibrosis and significant anemiaNaval Daver, Aditi Shastri, Tapan Kadia, et al.
Frontiers in Oncology|November 18, 2014
A single case of rosai-dorfman disease marked by pathologic fractures, kidney failure, and liver cirrhosis treated with single-agent cladribineKoji Sasaki, Naveen Pemmaraju, Jason R Westin, et al.
Leukemia Research|September 15, 2014
Clinical significance of microcytosis in patients with primary myelofibrosisPaolo Strati, Naveen Pemmaraju, Zeev Estrov, et al.
The Lancet. Haematology|October 23, 2021
Harnessing the benefits of available targeted therapies in acute myeloid leukaemiaHagop Kantarjian, Nicholas J Short, Courtney DiNardo, et al.
Leukemia Research|August 26, 2021
Chronic myeloid leukemia, BCR-ABL1-positive, carrying NPM1 mutation - First case series from a single institutionPaul E Young, Rashmi Kanagal-Shamanna, Shimin Hu, et al.
Leukemia & Lymphoma|November 6, 2025
Durable complete remission with imatinib monotherapy in a patient with FIP1L1-PDGFRA rearranged myeloid neoplasm with extramedullary involvementVanthana Bharathi, Wei-Ying Jen, Sangeetha Venugopal, et al.
Leukemia & Lymphoma|May 25, 2019
Outcomes of patients with chronic phase chronic myeloid leukemia (CML-CP) after discontinuation of frontline ponatinib therapyPrajwal Boddu, Preetesh Jain, Gautam Borthakur, et al.
Pageof 44

Showing results (91-100 of 436) with videos related to

Sort By:
Pageof 44
American Journal of Hematology|January 23, 2016
Acute promyelocytic leukemia presented as a relapse of acute myeloid leukemiaCandida Vitale, Elias Jabbour, Xinyan Lu, et al.
Frontiers in Oncology|September 28, 2020
First Report of Sorafenib in Patients With Acute Myeloid Leukemia Harboring Non-Canonical <i>FLT3</i> MutationsNaval Daver, Allyson Price, Christopher B Benton, et al.
Blood Advances|January 4, 2018
Co-occurrence of <i>FLT3</i>-TKD and <i>NPM1</i> mutations defines a highly favorable prognostic AML groupPrajwal Boddu, Hagop Kantarjian, Gautam Borthakur, et al.
Leukemia Research|July 23, 2014
Phase II study of pomalidomide in combination with prednisone in patients with myelofibrosis and significant anemiaNaval Daver, Aditi Shastri, Tapan Kadia, et al.
Frontiers in Oncology|November 18, 2014
A single case of rosai-dorfman disease marked by pathologic fractures, kidney failure, and liver cirrhosis treated with single-agent cladribineKoji Sasaki, Naveen Pemmaraju, Jason R Westin, et al.
Leukemia Research|September 15, 2014
Clinical significance of microcytosis in patients with primary myelofibrosisPaolo Strati, Naveen Pemmaraju, Zeev Estrov, et al.
The Lancet. Haematology|October 23, 2021
Harnessing the benefits of available targeted therapies in acute myeloid leukaemiaHagop Kantarjian, Nicholas J Short, Courtney DiNardo, et al.
Leukemia Research|August 26, 2021
Chronic myeloid leukemia, BCR-ABL1-positive, carrying NPM1 mutation - First case series from a single institutionPaul E Young, Rashmi Kanagal-Shamanna, Shimin Hu, et al.
Leukemia & Lymphoma|November 6, 2025
Durable complete remission with imatinib monotherapy in a patient with FIP1L1-PDGFRA rearranged myeloid neoplasm with extramedullary involvementVanthana Bharathi, Wei-Ying Jen, Sangeetha Venugopal, et al.
Leukemia & Lymphoma|May 25, 2019
Outcomes of patients with chronic phase chronic myeloid leukemia (CML-CP) after discontinuation of frontline ponatinib therapyPrajwal Boddu, Preetesh Jain, Gautam Borthakur, et al.
Pageof 44